[Pharm-policy] FT page on patents versus patients

[love@cptech.org]

http://news.ft.com/ft/gx.cgi/ftc?pagename=View&c=Article&cid=FT3IBK8OYJC&live=true

This has linkes to a number of interesting FT articles, including a nice
profile of Zackie Achmat.

http://globalarchive.ft.com/globalarchive/articles.html?id=010420008599&query=AIDS
South Africa's Aids gadfly 


And this article about Chile

http://globalarchive.ft.com/globalarchive/articles.html?id=010616001247&query=Aids
 
 1.   Chile signs Aids drugs deal 

 
Chile signs Aids drugs deal 
FT.com site; Jun 16, 2001
BY MARK MULLIGAN IN SANTIAGO


Chile on Friday became the first Latin American country to sign a
comprehensive deal with drug companies that will significantly reduce
the cost of providing treatment to people suffering from HIV and Aids. 

   [snip]

Free treatment with double and triple therapy drug cocktails costs the
Chilean government some $700 a month per patient, which will be halved
under the new agreement. Some drugs are being offered with an 80 per
cent discount. 

The participating pharmaceutical companies include GlaxoSmithKline,
Merck Sharp & Dohme, Bristol Myers Squibb and Boehringer Ingelheim. 

   [snip]